The global investment platform, Investopia, has revealed one of the key outcomes of its annual conference held on 2-3 March 2023 in Abu Dhabi, which is the launch of ‘Smart Clinics’ in the United Arab Emirates and the wider Middle East region, a new concept in the healthcare sector that focuses on improving life quality and establishing wellness pathways.
Technology and precision healthcare are key components of the Smart Clinics program. The announcement came during the signing of a partnership with the Italian GKSD Investment Holding Group and Gruppo San Donato (GSD), the leading private hospital group in Italy.
The MoU was signed during Investopia 2023 Conference by Mr. Abdulla Al Saleh, Undersecretary at the Ministry of Economy, and Mr. Paolo Rotelli, Vice-President of Gruppo San Donato, in the presence of Mr. Abdulla bin Touq Al Marri, UAE Minister of Economy and Chairman of Investopia.
In March 2023, the two groups, GKSD Investment Holding and Gruppo San Donato, announced an investment of $136 million plus in new projects in the UAE and the region, including university infrastructure and smart clinics.
Abdullah Ahmad Al Saleh Under-Secretary UAE MoE
“The main objective of Investopia platform is to create a global system for investment in new economies, like the healthcare technology sector. We are pleased to witness the launch of smart clinics in the UAE during the Investopia 2023 conference in collaboration with GKSD Investment Holding and Gruppo San Donato. This confirms the vital role that Investopia plays today as a global business destination where investors can meet and explore investment opportunities in the new economic sectors.”
Mr. Kamel Ghribi, President of GKSD Investment Holding, said that “The contribution of the UAE in promoting economic development, through the Investopia platform, is commendable. Investopia aims to drive global investments in new economic sectors, including healthcare. We are very proud of our strong capabilities in healthcare management and services including acute care treatment, medical education, scientific research in the field of gene and cellular therapies worldwide, as well as the recent strides made in the development of precision medicine, aided by artificial intelligence. We remain focused on expanding cooperation in the MENA region, sharing our GKSD expertise.”
Mr. Rotelli stated that “At GKSD and Gruppo San Donato, our focus is to provide a healthcare infrastructure and expertise that aims to improve life quality by focusing on ‘wellness pathways’. We are also working on artificial intelligence-supported diagnostic programs that lead to a number of benefits. We are delighted to be a partner for Investopia 2023 to support awareness and development of modern healthcare in precision medicine, gene therapy and editing.”
